FDCTech, Inc. Restates Q1 2025 Financials: Key Highlights and Shareholder Implications
Major Restatement of Quarterly Results: What Investors Need to Know
FDCTech, Inc. (OTC: FDCT) has issued a significant Amendment No. 2 to its Q1 2025 10-Q, restating previously filed and amended quarterly financial statements for the period ended March 31, 2025. This move follows a recommendation from the Board of Directors, after consultations with management and the company’s independent registered public accounting firm. Investors should take note: the previously issued Q1 2025 financial statements should no longer be relied upon due to material errors.
Key Restatement Adjustments
- Subscription Receivable Reclassification: A subscription receivable has been moved from current assets to a contra-equity account.
- Previously Unrecorded Shares: 500,000 shares of common stock issued in October 2021 were not previously recorded in the company’s share register. These have now been recognized.
- Restricted Cash Presentation: The company has separately presented restricted cash representing client funds segregated under regulatory requirements.
- Noncontrolling Interest and Comprehensive Income Allocations Corrected: The company corrected the noncontrolling interest walk (ASC 810-10) and the allocation of accumulated other comprehensive income (ASC 220-10).
- Corrections to Results of Operations: The principal impact was in other income (expense), increasing net income for Q1 2025 by \$209,574.
- Segment Cost of Sales Reclassification: The cost of sales for Alchemytech Ltd. has been reclassified from the Technology & Software segment to the Brokerage segment.
- Lease Accounting Adjustments: The right-of-use asset and operating lease liabilities have been remeasured under ASC 842.
Impact on Financial Position
March 31, 2025 (Restated) vs December 31, 2024 (Restated)
- Total Assets: \$34,069,668 (Mar 31, 2025) vs \$33,768,927 (Dec 31, 2024)
- Total Liabilities: \$22,388,630 (Mar 31, 2025) vs \$27,297,576 (Dec 31, 2024)
- Total Stockholders’ Equity (including Noncontrolling Interest): \$7,681,038 (Mar 31, 2025) vs \$6,471,351 (Dec 31, 2024)
- Common Stock Outstanding: 391,084,729 shares (as of both dates)
- Client Funds Payable: \$17,453,282 (Mar 31, 2025) vs \$11,526,789 (Dec 31, 2024)
- Capitalized Software, Net: \$1,217,543 (Mar 31, 2025) vs \$1,163,309 (Dec 31, 2024)
- Investment in Affiliates (via subsidiary): \$36,062 (Mar 31, 2025)
- Noncontrolling Interest: \$14,199 (Mar 31, 2025) vs \$16,820 (Dec 31, 2024)
Corporate Status and Other Disclosures
- Company Status: FDCTech is a non-accelerated filer, smaller reporting company, and an emerging growth company.
- Shell Company Status: FDCTech affirms it is not a shell company.
- Exchange Listing: FDCTech common stock trades on OTC Markets under the symbol FDCT.
- Par Value: \$0.0001 per share for both common and preferred stock.
- Common Shares Outstanding (as of June 8, 2026): 393,084,729
- SEC Reporting: The company affirms it has made all required filings and is current.
Price-Sensitive and Shareholder-Impacting Items
- The restatement of Q1 2025 earnings and the associated increase in net income by \$209,574 is material and could affect investor sentiment and share valuation.
- The recognition of previously unrecorded shares and reclassification of key balance sheet items may impact shareholder equity calculations and could affect dilution analyses.
- The reclassification of client funds and restricted cash provides greater transparency into regulatory compliance and liquidity, which may be important for institutional and retail investors monitoring risk.
- The company’s affirmation of its non-shell status and compliance with SEC reporting requirements may be reassuring to current and prospective investors regarding regulatory standing.
Restatement Rationale and Next Steps
The Board initiated this restatement due to identified errors, in compliance with ASC Topic 250 (Accounting Changes and Error Corrections), and the SEC’s guidance on restatements. This action underscores the Company’s commitment to transparency and regulatory compliance.
Investors are advised to review the details in Note 2 to the unaudited condensed consolidated financial statements for a full breakdown of restatement impacts, as well as to monitor future SEC filings for any further developments.
Conclusion
FDCTech’s restatement of its Q1 2025 financials is a material event. The corrections increase reported net income for the period and provide revised clarity on share count, equity, and compliance with regulatory requirements. These changes are potentially price-sensitive, and shareholders should consider the implications for valuation, dilution, and company credibility. Monitoring ongoing disclosures and future filings is recommended.
Disclaimer: This article is for informational purposes only and does not constitute investment advice. Investors should review the full SEC filings and consult with their financial advisor before making investment decisions related to FDCTech, Inc. The author and publisher are not responsible for any actions taken based on the information provided above.
